EP 1171148 A2 20020116 - SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TREATMENT OF MEDICAL DESORDERS
Title (en)
SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR TREATMENT OF MEDICAL DESORDERS
Title (de)
BEHANDLUNG VON MEDIZINISCHEN STÖRUNGEN MIT LÖSLICHER TUMORNEKROSEFAKTOR REZEPTOR
Title (fr)
TRAITEMENT DE TROUBLES D'ORDRE MEDICAL PAR UN RECEPTEUR DE FACTEUR DE NECROSE TUMORALE SOLUBLE
Publication
Application
Priority
- US 0010565 W 20000419
- US 13007499 P 19990419
- US 13432099 P 19990514
- US 14395999 P 19990715
- US 14823499 P 19990811
- US 37382899 A 19990813
- US 16467699 P 19991110
- US 18486400 P 20000225
Abstract (en)
[origin: WO0062790A2] The invention pertains to methods for treating medical disorders characterized by elevated levels or abnormal expression of TNF alpha by administering a TNF alpha antagonist, such as recombinant TNFR:Fc.
IPC 1-7
IPC 8 full level
A61K 38/17 (2006.01)
CPC (source: EP)
A61K 38/1793 (2013.01); A61K 45/06 (2013.01); A61P 17/06 (2017.12); A61P 19/00 (2017.12); C07K 2319/30 (2013.01)
Citation (search report)
See references of WO 0062790A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0062790 A2 20001026; WO 0062790 A3 20010712; WO 0062790 A8 20010802; AU 4363200 A 20001102; CA 2366785 A1 20001026; CA 2366785 C 20120207; EP 1171148 A2 20020116
DOCDB simple family (application)
US 0010565 W 20000419; AU 4363200 A 20000419; CA 2366785 A 20000419; EP 00923525 A 20000419